Race Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Race Oncology has a total shareholder equity of A$18.3M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$20.2M and A$1.9M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$17.19m |
| Equity | AU$18.31m |
| Total liabilities | AU$1.92m |
| Total assets | AU$20.23m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: FN3's short term assets (A$17.4M) exceed its short term liabilities (A$1.9M).
Long Term Liabilities: FN3's short term assets (A$17.4M) exceed its long term liabilities (A$48.3K).
Debt to Equity History and Analysis
Debt Level: FN3 is debt free.
Reducing Debt: FN3 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FN3 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: FN3 has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 29.3% each year.